Cyberknife Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Liver: Preliminary Results

Table 1

Demographics of patients with nonresectable liver tumors treated with Stereotactic Body Radiation Therapy and baseline characteristics of the liver malignancies.

	HCC	IHC	LM
Subjects	6	3	8
Age (years)	^∗62.7 (52–81)	69.3 (61–86)	58.1 (42–77)
Gender (M : F)	4 : 2	2 : 1	3 : 5
Time from Dx to SBRT (months)	^∗5 (2–11)	8 (3–16)	5.4 (2–11)
Therapy prior SBRT
Surgery	0	1	3
RFA	2	0	5
TACE	2	0	0
ChemoTx	3	2	8
Radiation	0	0	0
Tumor characteristics
Number	^∗1(1)	1 (N/A)	1 (1–6)
Diameter Max (cm)	^∗9.3 (5–22)		4.6 (2–9)
Volume (cc)	^∗386 (106–1268)	384 (80–818)	167 (26–433)

Abbreviations: HCC = Hepatocellular carcinoma; IHC = Intrahepatic cholangiocarcioma; LM = Liver metastases; M : F = Male : Female ratio; Dx = diagnosis; SBRT = Stereotactic Body Radiation Therapy; RFA = Radiofrequency ablation; TACE = Trans-arterial chemoembolization. *Mean (range).